Colgate-Palmolive officer reports stock award and taxes

Colgate-Palmolive Chief Growth Officer John Hazlin reported equity compensation activity involving company common stock.

Rhea-AI Filing Summary

Colgate-Palmolive Chief Growth Officer John Hazlin reported equity compensation activity involving company common stock. On February 23, 2026, he acquired 12,803 shares through the vesting of performance-based restricted stock units granted under the incentive compensation plan. On the same date, 6,117 shares were disposed of at $97.10 per share to cover tax withholding related to that vesting. After these transactions, Hazlin directly owned 24,422 shares and indirectly held 5,452 shares through the issuer’s 401(k) plan trustee.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Hazlin John

Role Chief Growth Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	12,803	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	6,117	$97.10	$594K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 24,422 shares (Direct); Common Stock — 5,452 shares (Indirect, By Issuer's 401(k) Plan Trustee)

Footnotes (2)

1. F1. Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.
2. F2. Withholding of shares for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Colgate-Palmolive (CL) report for John Hazlin?

Colgate-Palmolive reported that Chief Growth Officer John Hazlin had performance-based restricted stock units vest into 12,803 common shares, and 6,117 shares were withheld to satisfy tax obligations tied to that vesting, all recorded as non-derivative common stock transactions.

How many Colgate-Palmolive (CL) shares did John Hazlin acquire in this Form 4?

John Hazlin acquired 12,803 Colgate-Palmolive common shares through the vesting of performance-based restricted stock units. These PBRSUs were earned under the company’s incentive compensation plan after meeting performance goals and were settled entirely in shares of common stock.

Why were 6,117 Colgate-Palmolive (CL) shares disposed of in Hazlin’s filing?

The 6,117 Colgate-Palmolive shares were withheld to pay tax liabilities arising from the vesting of performance-based restricted stock units. This tax-withholding disposition used shares valued at $97.10 each and is a non-cash method to satisfy associated tax obligations.

What is John Hazlin’s Colgate-Palmolive (CL) share ownership after these transactions?

After the reported transactions, John Hazlin directly owned 24,422 Colgate-Palmolive common shares. He also had an additional 5,452 shares held indirectly through the issuer’s 401(k) plan trustee, reflecting both direct and retirement-plan-related equity exposure.

What are PBRSUs mentioned in the Colgate-Palmolive (CL) Form 4 footnotes?

PBRSUs, or performance-based restricted stock units, are share-based awards that vest only if specific performance goals are achieved. In this case, Hazlin’s earned PBRSUs were settled solely in Colgate-Palmolive common stock after a completed performance period under the incentive compensation plan.

How is the indirect Colgate-Palmolive (CL) ownership held for John Hazlin?

John Hazlin’s indirect ownership of Colgate-Palmolive shares, totaling 5,452, is held by the issuer’s 401(k) plan trustee. This reflects shares credited to his account within the company’s retirement plan, rather than directly in his personal brokerage account.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 04:26 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hazlin John

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Growth Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		A(1)		12,803	A	$0.0000	30,539	D
Common Stock	02/23/2026		F(2)		6,117	D	$97.1	24,422	D
Common Stock								5,452	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.

2. Withholding of shares for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan.

	/s/ Kristine Hutchinson, Attorney-in-Fact	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.